530 related articles for article (PubMed ID: 21806473)
1. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
[TBL] [Abstract][Full Text] [Related]
2. Improved transduction efficiency of a lentiviral vector for neuron-specific retrograde gene transfer by optimizing the junction of fusion envelope glycoprotein.
Kato S; Kobayashi K; Kobayashi K
J Neurosci Methods; 2014 Apr; 227():151-8. PubMed ID: 24613797
[TBL] [Abstract][Full Text] [Related]
3. A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein.
Kato S; Kobayashi K; Inoue K; Kuramochi M; Okada T; Yaginuma H; Morimoto K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Feb; 22(2):197-206. PubMed ID: 20954846
[TBL] [Abstract][Full Text] [Related]
4. Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein.
Kato S; Inoue K; Kobayashi K; Yasoshima Y; Miyachi S; Inoue S; Hanawa H; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2007 Nov; 18(11):1141-51. PubMed ID: 17944573
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient retrograde gene transfer into motor neurons by a lentiviral vector pseudotyped with fusion glycoprotein.
Hirano M; Kato S; Kobayashi K; Okada T; Yaginuma H; Kobayashi K
PLoS One; 2013; 8(9):e75896. PubMed ID: 24086660
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the transduction efficiency of a lentiviral vector for neuron-specific retrograde gene delivery through the point mutation of fusion glycoprotein type E.
Kato S; Sugawara M; Kobayashi K; Kimura K; Inoue KI; Takada M; Kobayashi K
J Neurosci Methods; 2019 Jan; 311():147-155. PubMed ID: 30347222
[TBL] [Abstract][Full Text] [Related]
7. Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.
Carpentier DC; Vevis K; Trabalza A; Georgiadis C; Ellison SM; Asfahani RI; Mazarakis ND
Gene Ther; 2012 Jul; 19(7):761-74. PubMed ID: 21900965
[TBL] [Abstract][Full Text] [Related]
8. Targeted transgene expression in rat brain using lentiviral vectors.
Jakobsson J; Ericson C; Jansson M; Björk E; Lundberg C
J Neurosci Res; 2003 Sep; 73(6):876-85. PubMed ID: 12949915
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
10. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
11. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
Kremer KL; Dunning KR; Parsons DW; Anson DS
J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent gene transduction using gammaretroviral and lentiviral vectors pseudotyped with chimeric vesicular stomatitis virus glycoprotein.
Kameyama Y; Kawabe Y; Ito A; Kamihira M
J Virol Methods; 2008 Oct; 153(1):49-54. PubMed ID: 18606189
[TBL] [Abstract][Full Text] [Related]
13. Altering Entry Site Preference of Lentiviral Vectors into Neuronal Cells by Pseudotyping with Envelope Glycoproteins.
Kobayashi K; Kato S; Inoue K; Takada M; Kobayashi K
Methods Mol Biol; 2016; 1382():175-86. PubMed ID: 26611586
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
[TBL] [Abstract][Full Text] [Related]
15. Transduction of human islets with the lentiviral vector.
Kobayashi N; Arata T; Okitsu T; Ikeda H; Kobayashi K; Kosaka Y; Narushima M; Tanaka N; Lakey JR
Transplant Proc; 2004 Sep; 36(7):2203-4. PubMed ID: 15518800
[TBL] [Abstract][Full Text] [Related]
16. Retrograde Transgene Expression via Neuron-Specific Lentiviral Vector Depends on Both Species and Input Projections.
Otsuka Y; Tsuge H; Uezono S; Tanabe S; Fujiwara M; Miwa M; Kato S; Nakamura K; Kobayashi K; Inoue KI; Takada M
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372593
[TBL] [Abstract][Full Text] [Related]
17. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
18. Pseudotyped lentiviral vectors for tract-targeting and application for the functional control of selective neural circuits.
Kato S; Kobayashi K
J Neurosci Methods; 2020 Oct; 344():108854. PubMed ID: 32663549
[TBL] [Abstract][Full Text] [Related]
19. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA
J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
[TBL] [Abstract][Full Text] [Related]
20. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.
Desmaris N; Bosch A; Salaün C; Petit C; Prévost MC; Tordo N; Perrin P; Schwartz O; de Rocquigny H; Heard JM
Mol Ther; 2001 Aug; 4(2):149-56. PubMed ID: 11482987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
